chr2-102718551-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032718.5(MFSD9):c.1294G>A(p.Val432Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,460,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032718.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFSD9 | NM_032718.5 | c.1294G>A | p.Val432Ile | missense_variant | 6/6 | ENST00000258436.10 | NP_116107.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFSD9 | ENST00000258436.10 | c.1294G>A | p.Val432Ile | missense_variant | 6/6 | 1 | NM_032718.5 | ENSP00000258436 | P1 | |
MFSD9 | ENST00000437075.6 | c.*1095G>A | 3_prime_UTR_variant, NMD_transcript_variant | 7/7 | 5 | ENSP00000414870 | ||||
MFSD9 | ENST00000438943.5 | c.*1130G>A | 3_prime_UTR_variant, NMD_transcript_variant | 7/7 | 5 | ENSP00000408630 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000850 AC: 21AN: 247146Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 134198
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1460360Hom.: 0 Cov.: 34 AF XY: 0.00000413 AC XY: 3AN XY: 726534
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.1294G>A (p.V432I) alteration is located in exon 6 (coding exon 6) of the MFSD9 gene. This alteration results from a G to A substitution at nucleotide position 1294, causing the valine (V) at amino acid position 432 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at